Company
Investment-firm
Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Jnana Therapeutics
Jnana Therapeutics is a biotech company that creates therapies to improve patients' lives.
Sector
Subsector
Keywords
Location
total rounds
total raised
VectivBio
VectivBio is a clinical-stage biotech targeting rare diseases with transformative therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
Aviceda Therapeutics
Aviceda Therapeutics is a biotech company developing drugs for treating glyco-immune diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Finch Therapeutics
Finch Therapeutics is a microbiome engineering company that develops microbial therapies for patients with unmet medical needs.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 24.02.2021. Their latest investor Surveyor Capital. Their latest round Series C
Logos Capital
Logos Capital is a San Francisco VC firm investing in biotech startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Boxer Capital
Boxer Capital supports biotech public companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Nextech Invest
Nextech Invest is a venture capital and private equity firm that focuses on precision therapies in oncology.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Celgene
Celgene develops and sells innovative therapies for cancer and immune-inflammatory diseases.
Sector
Subsector
Location
count Of Investments
count Of Exists
Investments1
Tavros Therapeutics
Tavros Therapeutics is an emerging biotech company focused on discovering and developing cancer therapies.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
Investors17
Number of lead investors
Number of investors
Surveyor Capital
Surveyor Capital is an investment firm that increases access and opportunity for companies and entrepreneurs.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
T. Rowe Price
T. Rowe Price is an investment management firm that funds technology startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
SoftBank Vision Fund
This company challenges traditional marketing and creates new possibilities for growth.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders3
Phil Baran
Phil Baran serves as a founder at Vividion Therapeutics.
current job
organization founded
Phil Baran
Benjamin Cravatt
Benjamin F. Cravatt, Ph.D., is a the Gilula Chair of Chemical Biology and Professor in the Department of Chemistry at The Scripps Research Institute. His research group develops and applies chemical proteomic technologies for protein and drug discovery on a global scale and has particular interest in studying biochemical pathways in the nervous system and cancer. Dr. Cravatt is a co-founder of Activx Biosciences (acquired by Kyorin Pharmaceuticals), Abide Therapeutics (acquired by Lundbeck Pharmaceuticals), and Vividion Therapeutics. His honors include a Searle Scholar Award, the Eli Lilly Award in Biological Chemistry, a Cope Scholar Award, the ASBMB Merck Award, the Royal Society of Chemistry Jeremy Knowles Award, and memberships in the National Academy of Sciences, National Academy of Medicine, and American Academy of Arts and Sciences. Ben obtained his undergraduate education at Stanford University, receiving a B.S. in the Biological Sciences and a B.A. in History. He then received a Ph.D. from The Scripps Research Institute (TSRI) in 1996, and joined the faculty at TSRI in 1997.
current job
organization founded
Benjamin Cravatt
Jin-Quan Yu
Vividion Therapeutics is a founder at Vividion Therapeutics.
current job
organization founded
Jin-Quan Yu
Employee Profiles14
Jean Bemis
Senior Vice President of Operations and Alliances
Monique Spoth
Executive assistant and office manager
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range